إعلان
إعلان
SRPT
Sarepta Therapeutics,, Inc. Common Stock
23.83
USDبرعاية
+0.68
+2.92%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
23.77
-0.06
-0.26%
تقارير أرباح SRPT
النسبة الإيجابية المفاجئة
SRPT تفوق 18 من 40 آخر التقديرات.
45%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$388.56M
/-$1.44
التغير الضمني من Q3 25 (Revenue/ EPS)
-2.70%
/+14300.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-40.99%
/-196.00%
Sarepta Therapeutics,, Inc. Common Stock earnings per share and revenue
On ٠٣ نوفمبر ٢٠٢٥, SRPT reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.83 USD, resulting in a 98.80% surprise. Revenue reached 399.36 مليون, compared to an expected 345.48 مليون, with a 15.59% difference. The market reacted with a -33.74% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 26 المحللين forecast an EPS of -1.44 USD, with revenue projected to reach 388.56 مليون USD, implying an زيادة of 14300.00% EPS, and نقصان of -2.70% in Revenue from the last quarter.
الأسئلة الشائعة
What were Sarepta Therapeutics,, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Sarepta Therapeutics,, Inc. Common Stock reported EPS of -$0.01, beating estimates by 98.8%, and revenue of $399.36M, 15.59% above expectations.
How did the market react to Sarepta Therapeutics,, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -33.74%, changed from $24.45 before the earnings release to $16.20 the day after.
When is Sarepta Therapeutics,, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Sarepta Therapeutics,, Inc. Common Stock's next earnings report?
Based on 26
المحللين, Sarepta Therapeutics,, Inc. Common Stock is expected to report EPS of -$1.44 and revenue of $388.56M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان